The results validate conclusions drawn by Bagli et al. [1], who executed a examine that included ten patients diagnosed with CRAO who obtained HBOT. Along with obtaining twenty sessions of HBOT, oral acetazolamide and topical beta-blockers have been administered towards the patients at the earliest feasible time.“Dr. Weber and his workers have be